目的 分析吉林大学第一医院静脉用药调配中心60周岁以上老年住院患者注射用药药品类别情况，保障老年患者用药安全，提升用药合理性。方法 调取本院2019年6～12月60周岁以上老年住院患者由综合静脉用药调配中心调配注射剂用药信息，按照药物类别、科室、代表药进行分析。结果 共统计有价值的用药信息189 949条，共涉及药品品种184种。根据药物类别统计分析得到抗感染药、消化系统用药、中枢神经系统用药占比最高，依次为31.77%、26.90%、16.47%；按科室统计各药物类别中代表科室依次为呼吸科（15.93%）、肝胆胰外科（15.00%）、神经内科（28.43%）；抗感染药代表药为注射用磺苄西林钠（11.22%）、盐酸莫西沙星注射液（11.11%）；消化系统用药代表药为注射用泮托拉唑钠（48.14%）、中枢神经系统用药代表药为丹参川芎嗪注射液（26.61%）。结论 60～79周岁中老年人为本院老年患者用药主要群体。呼吸、消化以及中枢神经系统疾病成为老年群体高发疾病。临床应针对老年患者疾病特点及治疗目标制定个体化用药方案，降低老年患者用药风险。

Objective To analyze the categories of injection drugs for elderly inpatients over 60 years old in First Hospital of Jilin University pharmacy intravenous admixture service center, so as to ensure the safety of drug use for elderly patients and improve the rationality of drug use. Methods From June to December in 2019, the information of the elderly inpatients over 60 years old who were allocated injections by the comprehensive intravenous drug allocation center was collected and analyzed according to the drug category, department and representative drugs.Results There were 189 949 pieces of valuable medication information, involving 184 kinds of drugs. According to the statistical analysis of drug categories, the proportion of anti infective drugs, digestive system drugs and central nervous system drugs was the highest, accounting for 31.77%, 26.90%, and 16.47%, respectively. The representative departments of each drug category were respiratory department (15.93%), hepatobiliary and pancreatic surgery department (15.00%) and neurology department (28.43%). The representative drugs of anti-infective drugs were sulbenicillin sodium for injection (11.22%) and salt Moxifloxacin injection (11.11%), pantoprazole sodium for injection (48.14%) and Salvia miltiorrhiza Ligustrazine Injection (26.61%) were the representative drugs of digestive system. Conclusion The elderly aged 60—79 are the high risk population. Respiratory, digestive and central nervous system diseases have become the high incidence diseases of the elderly. In order to reduce the medication risk of elderly patients, individualized medication plan should be made according to the disease characteristics and treatment goals of elderly patients.

R969.3